Search Results - "Dupuis, Jehan"

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies by Meignan, Michel, Cottereau, Anne Ségolène, Versari, Annibale, Chartier, Loïc, Dupuis, Jehan, Boussetta, Sami, Grassi, Ilaria, Casasnovas, René-Olivier, Haioun, Corinne, Tilly, Hervé, Tarantino, Vittoria, Dubreuil, Julien, Federico, Massimo, Salles, Gilles, Luminari, Stefano, Trotman, Judith

“…Identifying patients at high risk of progression and early death among those with high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current…”
Get full text

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial by Wang, Michael, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Casasnovas, Olivier, Smith, Stephen D, Damaj, Gandhi, Doorduijn, Jeanette, Lamy, Thierry, Morschhauser, Franck, Panizo, Carlos, Shah, Bijal, Davies, Andrew, Eek, Richard, Dupuis, Jehan, Jacobsen, Eric, Kater, Arnon P, Le Gouill, Steven, Oberic, Lucie, Robak, Taduesz, Covey, Todd, Dua, Richa, Hamdy, Ahmed, Huang, Xin, Izumi, Raquel, Patel, Priti, Rothbaum, Wayne, Slatter, J Greg, Jurczak, Wojciech

“…Bruton tyrosine kinase is a clinically validated target in mantle cell lymphoma. Acalabrutinib (ACP-196) is a highly selective, potent Bruton tyrosine kinase…”
Get full text

Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study by Cartron, Guillaume, de Guibert, Sophie, Dilhuydy, Marie-Sarah, Morschhauser, Franck, Leblond, Veronique, Dupuis, Jehan, Mahe, Beatrice, Bouabdallah, Reda, Lei, Guiyuan, Wenger, Michael, Wassner-Fritsch, Elisabeth, Hallek, Michael

“…GAUGUIN evaluated the safety and efficacy of obinutuzumab (GA101) monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia (CLL). In phase…”
Get full text

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study by Cottereau, Anne Ségolène, Versari, Annibale, Luminari, Stefano, Dupuis, Jehan, Chartier, Loïc, Casasnovas, René-Olivier, Berriolo-Riedinger, Alina, Menga, Massimo, Haioun, Corinne, Tilly, Hervé, Tarantino, Vittoria, Federico, Massimo, Salles, Gilles, Trotman, Judith, Meignan, Michel

“…Both total metabolic tumor volume (TMTV), computed on baseline positron emission tomography (PET), and end of induction (EOI) PET are imaging biomarkers…”
Get full text

An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's Syndrome by Michallet, Anne-Sophie, Sesques, Pierre, Rabe, Kari G., Itti, Emmanuel, Tordot, Jérémy, Tychyj-Pinel, Christelle, Baseggio, Lucile, Subtil, Fabien, Salles, Gilles, Dupuis, Jehan M., Conte, Michael J.

Get full text

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab by SAFAR, Violaine, DUPUIS, Jehan, MEIGNAN, Michel, HAIOUN, Corinne, ITTI, Emmanuel, JARDIN, Fabrice, FRUCHART, Christophe, BARDET, Stéphane, VERA, Pierre, COPIE-BERGMAN, Christiane, RAHMOUNI, Alain, TILLY, Hervé

“…The prognostic value of [(18)F]fluorodeoxyglucose-positron emission tomography (PET), interpreted according to visual criteria, is a matter of debate for…”
Get full text

Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers by Rossi, Cédric, Gilhodes, Julia, Maerevoet, Marie, Herbaux, Charles, Morschhauser, Franck, Brice, Pauline, Garciaz, Sylvain, Borel, Cécile, Ysebaert, Loïc, Obéric, Lucie, Lazarovici, Julien, Deau, Bénédicte, Dupuis, Jehan, Chauchet, Adrien, Abraham, Julie, Bijou, Fontanet, Stamatoullas‐Bastard, Aspasia, Malfuson, Jean‐Valère, Golfier, Camille, Laurent, Camille, Pericart, Sarah, Traverse‐Glehen, Alexandra, Kanoun, Salim, Filleron, Thomas, Casasnovas, René‐Olivier, Ghesquières, Hervé

“…Anti‐PD‐1 therapy provides high response rates in Hodgkin lymphoma (HL) patients who have relapsed or are refractory (R/R) to autologous stem cell…”
Get full text

Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS by DUPUIS, Jehan, BERRIOLO-RIEDINGER, Alina, COLOMBAT, Philippe, LAURENT, Guy, BERENGER, Nathalie, CASASNOVAS, Rene-Olivier, VERA, Pierre, PAONE, Gaetano, XERRI, Luc, SALLES, Gilles, HAIOUN, Corinne, MEIGNAN, Michel, JULIAN, Anne, BRICE, Pauline, TYCHYJ-PINEL, Christelle, TILLY, Herve, MOUNIER, Nicolas, GALLAMINI, Andrea, FEUGIER, Pierre, SOUBEYRAN, Pierre

“…[(18)F]Fluorodeoxyglucose positron emission tomography (PET) is widely used for the staging and restaging of patients with aggressive lymphoma, but less is…”
Get full text

Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO) by Simon, Laurence, Fitsiori, Aikaterini, Lemal, Richard, Dupuis, Jehan, Carpentier, Benjamin, Boudin, Laurys, Corby, Anne, Aurran-Schleinitz, Thérèse, Gastaud, Lauris, Talbot, Alexis, Leprêtre, Stéphane, Mahe, Béatrice, Payet, Camille, Soussain, Carole, Bonnet, Charlotte, Vincent, Laure, Lissandre, Séverine, Herbrecht, Raoul, Kremer, Stéphane, Leblond, Véronique, Fornecker, Luc-Matthieu

“…Central nervous system involvement by malignant cells is a rare complication of Waldenström macroglobulinemia, and this clinicopathological entity is referred…”
Get full text

Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine by Gressens, Simon B., Enouf, Vincent, Créon, Antoine, Melica, Giovanna, Lemonnier, Francois, Dupuis, Jehan, El Gnaoui, Taoufik, Hammoud, Mohammad, Belhadj, Karim, Haioun, Corinne, Le Bouter, Anne, Gallien, Sebastien, Bras, Fabien Le, Fourati, Slim

“…•Multiple myeloma patients have poor serological responses after influenza vaccination.•Treatment with daratumumab (anti-CD38) does not seem to further impair…”
Get full text

Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort by Bouclet, Florian, Calleja, Anne, Dilhuydy, Marie-Sarah, Véronèse, Lauren, Pereira, Bruno, Amorim, Sandy, Cymbalista, Florence, Herbaux, Charles, de Guibert, Sophie, Roos-Weil, Damien, Hivert, Bénédicte, Aurran, Thérèse, Dupuis, Jehan, Blouet, Anaise, Tchernonog, Emmanuelle, Laribi, Kamel, Dmytruck, Nataliya, Morel, Pierre, Michallet, Anne-Sophie, Dartigeas, Caroline, Tournilhac, Olivier, Nguyen-Khac, Florence, Delmer, Alain, Feugier, Pierre, Ysebaert, Loïc, Guièze, Romain

“…The BCL2 inhibitor venetoclax is transforming the management of patients with chronic lymphocytic leukemia (CLL), given its high efficacy in…”
Get full text

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association by Sarkozy, Clémentine, Molina, Thierry, Ghesquières, Hervé, Michallet, Anne-Sophie, Dupuis, Jehan, Damotte, Diane, Morsschauser, Franck, Parrens, Marie, Martin, Laurent, Dartigues, Peggy, Stamatoullas, Aspasia, Hirsch, Pierre, Fabiani, Bettina, Bouabdallah, Krimo, da Silva, Maria Gomes, Maerevoet, Marie, Laurent, Camille, Coiffier, Bertrand, Salles, Gilles, Traverse-Glehen, Alexandra

“…Mediastinal gray zone lymphoma, B-cell lymphomas with intermediate features between classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma, have…”
Get full text

Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group by Carras, Sylvain, Torroja, Alexia, Emadali, Anouk, Montaut, Emilie, Daguindau, Nicolas, Tempescul, Adrian, Moreau, Anne, Tchernonog, Emmanuelle, Schmitt, Anna, Houot, Roch, Dartigeas, Caroline, Barbieux, Sarah, Corm, Selim, Banos, Anne, Fouillet, Ludovic, Dupuis, Jehan, Macro, Margaret, Fleury, Joel, Jardin, Fabrice, Sarkozy, Clementine, Damaj, Ghandi, Feugier, Pierre, Fornecker, Luc Matthieu, Chabrot, Cecile, Dorvaux, Veronique, Bouabdallah, Krimo, Amorim, Sandy, Garidi, Reda, Voillat, Laurent, Joly, Bertrand, Morineau, Nadine, Moles, Marie Pierre, Zerazhi, Hacene, Fontan, Jean, Arkam, Yazid, Alexis, Magda, Delwail, Vincent, Vilque, Jean Pierre, Ysebaert, Loic, Burroni, Barbara, Callanan, Mary, Le Gouill, Steven, Gressin, Rémy

“…Between 2011 and 2012, a phase II trial evaluated the use of the RiBVD (rituximab, bendamustine, velcade and dexamethasone) combination as first-line treatment…”
Get full text

High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline by Rossi, Cédric, André, Marc, Dupuis, Jehan, Morschhauser, Franck, Joly, Bertrand, Lazarovici, Julien, Ghesquières, Hervé, Stamatoullas, Aspasia, Nicolas-Virelizier, Emmanuelle, Feugier, Pierre, Gac, Anne-Claire, Moatti, Hannah, Fornecker, Luc-Matthieu, Deau, Bénédicte, Joubert, Clémentine, Fortpied, Catherine, Raemaekers, John, Federico, Massimo, Kanoun, Salim, Meignan, Michel, Traverse-Glehen, Alexandra, Cottereau, Anne-Ségolène, Casasnova, René-Olivier

“…Stage IIB Hodgkin lymphoma (HL) patients, with a mediastinum-to-thorax (M/T) ratio of ≥0.33 or extranodal localization have a poor prognosis and are treated…”
Get full text

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma by Gressin, Rémy, Daguindau, Nicolas, Tempescul, Adrian, Moreau, Anne, Carras, Sylvain, Tchernonog, Emmanuelle, Schmitt, Anna, Houot, Roch, Dartigeas, Caroline, Pignon, Jean Michel, Corm, Selim, Banos, Anne, Mounier, Christiane, Dupuis, Jehan, Macro, Margaret, Fleury, Joel, Jardin, Fabrice, Sarkozy, Clementine, Damaj, Ghandi, Feugier, Pierre, Fornecker, Luc Matthieu, Chabrot, Cecile, Dorvaux, Veronique, Bouadallah, Krimo, Amorin, Sandy, Garidi, Reda, Voillat, Laurent, Joly, Bertrand, Celigny, Philippe Solal, Morineau, Nadine, Moles, Marie Pierre, Zerazhi, Hacene, Fontan, Jean, Arkam, Yazid, Alexis, Magda, Delwail, Vincent, Vilque, Jean Pierre, Ysebaert, Loic, Le Gouill, Steven, Callanan, Mary B

“…We present results of a prospective, multicenter, phase II study evaluating rituximab, bendamustine, bortezomib and dexamethasone as first-line treatment for…”
Get full text

Identification of prognostic markers in transthyretin and AL cardiac amyloidosis by Damy, Thibaud, Jaccard, Arnaud, Guellich, Aziz, Lavergne, David, Galat, Arnault, Deux, Jean-François, Hittinger, Luc, Dupuis, Jehan, Frenkel, Valérie, Rigaud, Charlotte, Plante-Bordeneuve, Violaine, Bodez, Diane, Mohty, Dania

“…Background: The prognosis of amyloidosis is known to depend heavily on cardiac function and may be improved by identifying patients at highest risk for adverse…”
Get full text

Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group by Sibon, David, Morschhauser, Franck, Resche-Rigon, Matthieu, Ghez, David, Dupuis, Jehan, Marçais, Ambroise, Deau-Fischer, Bénédicte, Bouabdallah, Reda, Sebban, Catherine, Salles, Gilles, Brice, Pauline

“…We assessed the long-term results of autologous stem-cell transplantation for patients with first-relapsed or refractory Hodgkin lymphoma included in the…”
Get full text

A prognostic index predicting survival in transformed Waldenström macroglobulinemia by Durot, Eric, Kanagaratnam, Lukshe, Zanwar, Saurabh, Kastritis, Efstathios, D’Sa, Shirley, Garcia-Sanz, Ramon, Tomowiak, Cécile, Hivert, Bénédicte, Toussaint, Elise, Protin, Caroline, Abeykoon, Jithma P., Guerrero-Garcia, Thomas, Itchaki, Gilad, Vos, Josephine M., Michallet, Anne-Sophie, Godet, Sophie, Dupuis, Jehan, Leprêtre, Stéphane, Bomsztyk, Joshua, Morel, Pierre, Leblond, Véronique, Treon, Steven P., Dimopoulos, Meletios A., Kapoor, Prashant, Delmer, Alain, Castillo, Jorge J.

“…Histological transformation into diffuse large B-cell lymphoma is a rare complication in patients with Waldenström macroglobulinemia (WM) and is usually…”
Get full text

Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire by LE GOUILL, Steven, MILPIED, Noel, RIO, Bernard, GRATECOS, Nicole, YAKOUB-AGHA, Ibrahim, ATTAL, Michel, TOURNILHAC, Olivier, DECAUDIN, Didier, BOURHIS, Jean-Henry, BLAISE, Didier, VOLTEAU, Christelle, MICHALLET, Mauricette, BUZYN, Agnès, PEFFAULT DE LATOUR, Régis, VERNANT, Jean-Paul, MOHTY, Mohamad, MOLES, Marie-Pierre, BOUABDALLAH, Krimo, BULABOIS, Claude-Eric, DUPUIS, Jehan

“…Aggressive T-cell lymphomas (ATCLs) represent 10% to 15% of non-Hodgkin's lymphomas (NHLs) in adults. ATCLs show a worse prognosis than B-cell lymphomas. On…”
Get full text

Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis by Le Bras, Fabien, Molinier-Frenkel, Valerie, Guellich, Aziz, Dupuis, Jehan, Belhadj, Karim, Guendouz, Soulef, Ayad, Karima, Colombat, Magali, Benhaiem, Nicole, Tissot, Claire Marie, Hulin, Anne, Jaccard, Arnaud, Damy, Thibaud

“…Abstract Chemotherapy combining cyclophosphamide, bortezomib and dexamethasone is widely used in light-chain amyloidosis. The benefit is limited in patients…”
Get full text